株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

デジタル病理学の世界市場予測 2022年:スキャナー・ソフトウェア・通信システム

Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 251934
出版日 ページ情報 英文 156 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.38円で換算しております。
Back to Top
デジタル病理学の世界市場予測 2022年:スキャナー・ソフトウェア・通信システム Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022
出版日: 2017年10月16日 ページ情報: 英文 156 Pages
概要

世界のデジタル病理学市場規模は、2017年から2022年にかけて12.3%のCAGR (年間複合成長率) で推移し、2016年の3億8,390万米ドルから2022年までに7億5,610万米ドルへ達すると予測されています。同市場の成長の背景には、創薬およびコンパニオン診断におけるデジタル病理学適用の増加、コンサルテーションのし易さ、研究所の効率を高めるためのデジタル病理学適用の増加、癌の有病率増加、政府および企業による取り組みの増加などが挙げられます。

当レポートでは、世界のデジタル病理学市場を取り上げ、市場の概要・動向を概括し、タイプ・エンドユーザー・アプリケーション・地域別による市場分析・予測、競合情勢の分析、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • デジタル病理学市場の概要
  • 欧州市場のシェア:アプリケーション/国別
  • 世界市場:タイプ別・国別
  • デジタル病理学市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 促進因子
    • 阻害因子
    • 機会
  • 規制の枠組み

第6章 デジタル病理学市場:製品別

  • イントロダクション
  • スキャナー
  • ソフトウェア
  • 通信システム
  • ストレージシステム

第7章 デジタル病理学市場:タイプ別

  • イントロダクション
  • 人体デジタル病理学
  • 動物デジタル病理学

第8章 デジタル病理学市場:アプリケーション別

  • イントロダクション
  • 遠隔医療相談
  • 病気の診断
  • 創薬
  • トレーニング・教育

第9章 デジタル病理学市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 病院および参考検査室
  • 学術・研究機関

第10章 世界のデジタル病理学市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域(ROW)

第11章 企業プロファイル

  • Leica Biosystems
  • Ventana Medical Systems
  • 浜松ホトニクス
  • 3DHISTECH
  • Koninklijke Philips
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm
  • Corista
  • Indica Labs
  • Objective Pathology Services

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HIT 2608

"The digital pathology market is projected to grow at a CAGR of 12.3%."

The global digital pathology market is expected to grow at a CAGR of 12.3% to reach to USD 756.1 million by 2022. Growth in the digital pathology market is mainly driven by factors such as the rising prevalence of cancer, growing applications of digital pathology in drug development and companion diagnostics, ease of consultation, increasing adoption of digital pathology to enhance lab efficiency, and increasing initiatives by governments and industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent. Lack of standard guidelines may also challenge market growth in the coming years.

"The software segment to account for the largest share of the market."

By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment is estimated to account for the largest share of the global digital pathology market in 2017. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe.

"The pharmaceutical and biotechnology companies segment to hold the largest market share in 2017."

On the basis of end user, the digital pathology market is classified into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the digital pathology market. Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, and molecular assays.

"North America to dominate the digital pathology market and APAC projected to grow at the highest CAGR during the forecast period."

The North American region is expected to hold the largest share of the global digital pathology market in 2017. The large share of this region can be attributed to factors such as the rising prevalence of chronic diseases and increasing initiatives by industry players and governments in diagnostics. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
  • By Designation - C-level: 27%, Director Level: 15%, Others: 58%
  • By Region - North America: 45%, Europe: 29%, Asia Pacific: 20%, RoW: 6%

Leica Biosystems (Germany), Ventana Medical Systems (US), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), and Philips (Netherlands) are the key players in the digital pathology market.

Research Coverage:

The report analyzes the digital pathology market and aims at estimating the market size and the future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global digital pathology market
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global digital pathology market
  • Market Development: Comprehensive information about the lucrative emerging markets by product, type, application, end user, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global digital pathology market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVRED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. DIGITAL PATHOLOGY: MARKET OVERVIEW
  • 4.2. EUROPEAN DIGITAL PATHOLOGY MARKET SHARE, BY APPLICATION AND COUNTRY (2017)
  • 4.3. DIGITAL PATHOLOGY MARKET, BY TYPE VS. COUNTRY 2017 VS. 2022
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of digital pathology to enhance lab efficiency
      • 5.2.1.2. Rising prevalence of cancer
      • 5.2.1.3. Growing applications of digital pathology in drug development and companion diagnostics
      • 5.2.1.4. Ease of consultation enabled by digital pathology
      • 5.2.1.5. Increasing initiatives by governments and industry players
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of digital pathology systems
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Overcoming the shortage of pathologists through digital pathology
      • 5.2.3.2. Introduction of affordable scanners for private pathology practices
      • 5.2.3.3. Personalized medicine
      • 5.2.3.4. Integration of laboratory information systems (LIS) and digital pathology systems
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of standard guidelines
  • 5.3. REGULATORY IMPLICATIONS
    • 5.3.1. HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
    • 5.3.2. CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)

6. DIGITAL PATHOLOGY MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SCANNERS
  • 6.3. SOFTWARE
  • 6.4. COMMUNICATION SYSTEMS
  • 6.5. STORAGE SYSTEMS

7. DIGITAL PATHOLOGY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. HUMAN PATHOLOGY
  • 7.3. VETERINARY PATHOLOGY

8. DIGITAL PATHOLOGY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. TELECONSULTATION
  • 8.3. DISEASE DIAGNOSIS
  • 8.4. DRUG DISCOVERY
  • 8.5. TRAINING AND EDUCATION

9. DIGITAL PATHOLOGY MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3. HOSPITALS AND REFERENCE LABORATORIES
  • 9.4. ACADEMIC & RESEARCH INSTITUTES

10. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Favorable reimbursement scenario for digital pathology in the US
      • 10.2.1.2. Rising cancer prevalence in the US
      • 10.2.1.3. De Novo application by the FDA
      • 10.2.1.4. Conferences and meetings in the US
    • 10.2.2. CANADA
      • 10.2.2.1. Growing need for quality cancer diagnosis in Canada
      • 10.2.2.2. Implementation of favorable initiatives by Canadian authorities
  • 10.3. EUROPE
    • 10.3.1. UK
      • 10.3.1.1. Initiatives adopted by NHS England promoting the adoption of digital pathology in the UK
      • 10.3.1.2. Technological developments in the UK market
      • 10.3.1.3. Organization of digital pathology-related conferences in the UK
    • 10.3.2. GERMANY
      • 10.3.2.1. Organization of digital pathology-related conferences in Germany
    • 10.3.3. SWEDEN
      • 10.3.3.1. Increasing government initiatives and deployment of digital pathology solutions
    • 10.3.4. DENMARK
      • 10.3.4.1. High cancer prevalence to boost market growth in Denmark
    • 10.3.5. REST OF EUROPE (ROE)
      • 10.3.5.1. Integration & deployment of digital pathology solutions in France
      • 10.3.5.2. Spain: implementation of digital pathology-related projects
      • 10.3.5.3. Digital pathology gaining momentum in the Netherlands
  • 10.4. ASIA PACIFIC
    • 10.4.1. CHINA
      • 10.4.1.1. Industry initiatives to boost digital pathology market in China
      • 10.4.1.2. Favorable initiatives for the adoption of telepathology in China
    • 10.4.2. JAPAN
      • 10.4.2.1. Initiatives by industry players for cancer diagnosis
    • 10.4.3. INDIA
      • 10.4.3.1. Increasing incidence of cancer in India
    • 10.4.4. REST OF ASIA PACIFIC
      • 10.4.4.1. Cancer control initiatives in Australia
  • 10.5. ROW
      • 10.5.1.1. Potential for the growth of digital pathology in Africa
      • 10.5.1.2. Increasing focus of industry players on the Middle East

11. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 11.1. LEICA BIOSYSTEMS
  • 11.2. VENTANA MEDICAL SYSTEMS
  • 11.3. HAMAMATSU PHOTONICS
  • 11.4. 3DHISTECH
  • 11.5. KONINKLIJKE PHILIPS
  • 11.6. APOLLO ENTERPRISE IMAGING
  • 11.7. XIFIN
  • 11.8. HURON DIGITAL PATHOLOGY
  • 11.9. VISIOPHARM
  • 11.10. CORISTA
  • 11.11. INDICA LABS
  • 11.12. OBJECTIVE PATHOLOGY SERVICES

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 3: DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2015-2022 (UNITS)
  • TABLE 4: TYPES OF DIGITAL PATHOLOGY SOFTWARE
  • TABLE 5: DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 6: COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
  • TABLE 7: DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 8: DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 9: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 10: HUMAN PATHOLOGY MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 11: VETERINARY PATHOLOGY MARKET, BY COUNTRY/ REGION, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 13: DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 15: DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: DIGITAL PATHOLOGY MARKET FOR TRAINING AND EDUCATION, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 18: DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: DIGITAL PATHOLOGY MARKET FOR HOSPITAL AND REFERENCE LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: DIGITAL PATHOLOGY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: DIGITAL PATHOLOGY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
  • TABLE 28: US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 29: US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 31: US: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 41: UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 42: UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 50: SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 71: JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 72: JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 74: INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 75: INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 77: INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 78: ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 79: ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 81: ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 85: ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
  • FIGURE 2: GLOBAL DIGITAL PATHOLOGY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2017)
  • FIGURE 7: DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2017 VS. 2022
  • FIGURE 8: DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION (2017)
  • FIGURE 9: DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2017 VS. 2022
  • FIGURE 10: ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: INCREASING ADOPTION OF DIGITAL PATHOLOGY IS A MAJOR FACTOR DRIVING THE GROWTH OF THE DIGITAL PATHOLOGY MARKET
  • FIGURE 12: TELECONSULTATION IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 13: HUMAN PATHOLOGY TO CONTINUE TO DOMINATE THE DIGITAL PATHOLOGY MARKET IN 2022
  • FIGURE 14: CHINA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 15: DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NUMBER OF NEW CANCER CASES, BY COUNTRY, 2012 VS. 2020
  • FIGURE 17: SCANNERS SEGMENT TO DOMINATE THE DIGITAL PATHOLOGY PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: DIGITAL PATHOLOGY MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 19: TELECONSULTATION COMMANDS FOR LARGEST MARKET SIZE OF THE DIGITAL PATHOLOGY MARKET IN 2017, BY APPLICATION
  • FIGURE 20: GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2017-2022
  • FIGURE 21: DIGITAL PATHOLOGY MARKET, BY REGION, 2017
  • FIGURE 22: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 23: INCREASING PREVALENCE OF CANCER - A MAJOR FACTOR DRIVING THE NORTH AMERICAN MARKET
  • FIGURE 24: EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 25: EUROPE: NUMBER OF CANCER CASES REPORTED, BY COUNTRY
  • FIGURE 26: CANCER PREVALENCE IN DENMARK
  • FIGURE 27: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 28: NUMBER OF NEW CANCER CASES, BY TYPE
  • FIGURE 29: ROW: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 30: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 31: ROCHE GROUP: COMPANY SNAPSHOT
  • FIGURE 32: HAMAMATSU PHOTONICS: COMPANY SNAPSHOT
  • FIGURE 33: KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
Back to Top